Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 6, 2012
Center for Drug Evaluation and Research
3781a274-d4b8-4b5c-b800-79fcdaac4674
Related Documents
Study and Evaluation of Sex Differences in the Clinical Evaluation of Drugs: Guidance for Industry
Guidance DocumentJuly 22, 1993
Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
Guidance DocumentFebruary 4, 2010
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.